COMP <GO>
ALAB vs NVDA // ENTERPRISE SCALE & MARKET CAP
Astera Labs Inc. (NASDAQ) VS. NVIDIA Corporation (NASDAQ) • 15-METRIC TALLY: ALAB 6
— NVDA 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: NVDA
LAST: $258.70 (-10.93%) • MKT CAP: $50.39B
market-cap
$50.39B
LAST: $204.64 (-4.22%) • MKT CAP: $4.93T
market-cap
$4.93T
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALAB VS. NVDA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALAB | NVDA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 75.70% | 74.67% | +1.03 | ALAB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | 65.06% | -61.66 | NVDA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 23.2x | +71.79 | NVDA | /valuation <GO> |
| Free Cash Flow Yield | 0.56% | 2.58% | -2.02 | NVDA | /fcf-yield <GO> |
| Operating Margin | 20.30% | 65.21% | -44.91 | NVDA | /operating-margins <GO> |
| Net Profit Margin | 25.70% | 63.66% | -37.96 | NVDA | /net-margins <GO> |
| Revenue Growth (YoY) | 115.10% | 83.38% | +31.72 | ALAB | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.02% | -0.02 | NVDA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 19.52 | +6.48 | ALAB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 4/9 | +5.00 | ALAB | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 8.10% | 9.01% | -0.91 | ALAB | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.5 | 35.1 | +2.42 | ALAB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.34 | 2.04 | -0.70 | NVDA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 17.0x | +122.98 | NVDA | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $50.39B | $4.93T | -$4.88T | NVDA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALAB REV | NVDA REV | ALAB GROSS % | NVDA GROSS % | ALAB FCF | NVDA FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $215.94B | — | 71.1% | — | $96.68B |
| FY 2025 | $852.5M | $130.50B | 75.7% | 75.0% | $281.8M | $60.85B |
| FY 2024 | $396.3M | $60.92B | 76.4% | 72.7% | $102.4M | $27.02B |
| FY 2023 | $115.8M | $26.97B | 44.0% | 56.9% | -$17.9M | $3.81B |
| FY 2022 | — | $26.91B | — | 64.9% | — | $8.13B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALAB // BETA 1.34
NVDA // BETA 2.04